50-156-2810

PRMT3 Polyclonal Antibody, Bethyl Laboratories

Manufacturer: Bethyl Laboratories, Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-156-2810-Each-of-1 In Stock ₹ 12,384.35

50-156-2810 - Each of 1

₹ 12,384.35

In Stock

Quantity

1

Base Price: ₹ 12,384.35

GST (18%): ₹ 2,229.183

Total Price: ₹ 14,613.533

Antigen

PRMT3

Classification

Polyclonal

Formulation

TBS with 0.1% BSA and 0.09% sodium azide

Gene Accession No.

O60678

Gene Symbols

PRMT3

Immunogen

Between 1 and 50

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Applications

Western Blot

Conjugate

Unconjugated

Gene

PRMT3

Gene Alias

Hrmt1l3

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

10196

Content And Storage

4° C

Form

Liquid

Related Products

Img

Bethyl Laboratories, Inc

50-156-3355

--

Img

Bethyl Laboratories, Inc

50-156-2246

--

Img

Bethyl Laboratories, Inc

50-156-0080

--

Img

Bethyl Laboratories, Inc

50-156-3356

--

Img

Bethyl Laboratories, Inc

50-155-9432

--

Img

Bethyl Laboratories, Inc

50-156-8358

--

Img

Bethyl Laboratories, Inc

50-156-8732

--

Img

Bethyl Laboratories, Inc

50-156-0078

--

Description

  • The recommended shelf life for this product is 1 year from date of receipt
  • Arginine methylation is an irreversible post translational modification which has only recently been linked to protein activity
  • At least three types of PRMT enzymes have been identified in mammalian cells
  • These enzymes have been shown to have essential regulatory functions by methylation of key proteins in several fundamental areas
  • These protein include nuclear proteins, IL enhancer binding factor, nuclear factors, cell cycle proteins, signal transduction proteins, apoptosis proteins, and viral proteins
  • The mammalian PRMT family currently consists of 7 members that share two large domains of homology
  • Outside of these domains, epitopes were identified and antibodies against all 7 PRMT members have been developed.